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Cardiac output is determined, in large part, by the venous return ofblood to the heart. Various adrenergic
and pharmacologic influences affect venous return. In the dog it appears that the liver may play an
important role in the control of blood flow from the splanchnic to the central circulation and, hence, in the
control of venous return.
While much is known about the factors controlling cardiac function and systemic
blood pressure under both physiologic and pathologic conditions, relatively little is
known about the control of the venous circulation. Changes in the capacity of the
peripheral circulation importantly influence cardiac performance through the Frank
Starling mechanism.
The systemic venous system plays animportant rolein the regulation ofventricular
filling. About two-thirds of the circulating blood volume resides within the systemic
venous system in man [1]. Ofthe blood within the venous circulation, approximately
two-thirds to three-fourths resides within the small veins and venules; the remainder
is withinthelarge veins[1]. Thecapacity ofthe arterial system and ofthecapillaries is
relatively small. Unlike arterial resistance vessels, the capacitance vessels are affected
little by local metabolic changes. The overall control of venous circulatory activity is
mainly accomplished through autonomic nervous activity and circulating hormones
[1].
Exclusive of the heart and lungs, the three major areas within the venous system
which regulate blood volume are the cutaneous, skeletal muscle, and splanchnic
circulations as illustrated in Fig. 1 [2]. The pumping action of skeletal muscle during
exercise augments venous return to the heart bycompression ofskeletal muscle veins
[3]. This increase in venous return results in an increase in cardiac output by the
Frank Starling mechanism. While circulating substances such as drugs and catechol-
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FIG. 1. A schematic representation of the control of the systemic venous system [2]. See text for details.
amines may influence the capacity ofthe skeletal muscle venous system, sympathetic
neural control of the venous system in this area is minimal [2]. The venous system of
the skin can respond to sympathetic innervation and circulating substances, but this
latter system is a relatively small reservoir consisting of only several hundred
milliliters of blood [2].
The splanchnic circulation, however, is a rather extensive blood reservoir. In man,
approximately one-fifth of the total blood volume resides within the splanchnic
venous bed [2]. The areas within the splanchnic circulation which constitute this
blood reservoir include the spleen, the mesenteric vasculature, and the sinusoids of
the liver. The spleen has the potential of decreasing in size sufficiently to release as
much as one-third of the splanchnic venous volume of blood into the remainder of
the circulation [4]. The venous system of the mesenteric vasculature can contribute
between one-third and one-half ofthe splanchnic volume to the central blood volume
[4]. Lastly, the sinusoids of the liver are capable of releasing the remainder of the
splanchnic blood volume into the rest of the circulation [4]. Thus, the splanchnic
circulation has the capability ofaugmenting the central blood volumewithin the vena
cava, the heart, and the lungs by 600-700 ml and is of great potential importance in
the regulation of venous return in man.
It has been thought that the major mechanism of control of blood volume within
the splanchnic circulation consists of an action directly on blood vessels by sympa-
thetic innervation and circulating substances such as catecholamines [2]. A decrease
in systemic arterial pressure is accompanied by a decrease in theinhibitory influences
ofthe baroreceptors ofthe carotid sinus and aortic area onthe vasomotor centerand
a resultingincrease in sympathetic outflow. Anincreaseinsympathetic stimuli results
in a constriction of venous smooth muscle and mobilization of blood from the
splanchnic vasculature toward the heart.
It has been established that alpha adrenergic receptor stimulation, whether
secondary to increased sympathetic nerve activity or to circulating catecholamines,
results in constriction of veins of numerous organ systems, including skin, skeletal
muscle, and the kidney [2,5-10]. Alexander [11] has demonstrated that phenyleph-
rine, an alpha adrenergic receptor stimulating agent, increases the tone of isolated
segments of the mesenteric vasculature. Opdyke and Ward [12] have employed an
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exteriorized, continuously weighed canine spleen model, which is representative ofan
in situ segment ofthe portal circulation, to assess the effects of adrenergic stimulation
on the splenic smooth muscle capsule. The administration of norepinephrine and
epinephrine results in alpha adrenergic mediated splenic constriction in the dog, as
manifested by a decrease in spleen weight, which is abolished following alpha
receptor blockade with phentolamine.
Our recent preliminary data suggest that dobutamine, a new synthetic catechola-
mine recently developed as a therapeutic agent for the treatment of low cardiac
output states, decreases canine spleen weight by means of alpha adrenergic receptor
stimulation [13]. With the intravenous infusion of dobutamine (80jAg/min) in 15
anesthetized dogs spleen weight decreased 15 ± 3.8% (SEM) (p< .01) from a mean
control weight of 245 g. This was associated with a modest (7 ±2 mm Hg) decrease in
mean aortic pressure and a small (12 ±6 beats/ min) increase in heart rate. The splenic
constriction, however, could not be explained by a reflex mechanism, since dobuta-
mine produced constriction of comparable magnitude after splenic denervation and
adrenalectomy. Furthermore, intraarterial injections of dobutamine into the splenic
artery (80 Mg bolus) were associated with a decrease in spleen weight of 14 ± 1.5%
(p < .001) from a mean control weight of 294 g without associated significant
changes in mean blood pressure or heart rate. Alpha adrenergic receptor blockade
with phenoxybenzamine entirely abolished the dobutamine induced decrease in
spleen weight and uncovered a small, statistically insignificant increase in spleen
weight. Thus, alpha adrenergic receptor stimulation, whether by circulating hor-
mones or by therapeutic maneuvers, results in venoconstriction in the portal circula-
tion.
It is likely that the venoconstrictor effects of alpha adrenergic receptor stimulation
on both the splanchnic and the remainder of the peripheral vasculature, exclusive of
the heart, contributed to the increase in venous return noted by Kaiser, Ross, and
Braunwald [6] when they administered phenylephrine to the dog on total cardiopul-
monary bypass. However, in addition, this latter study demonstrated that beta
adrenergic receptor stimulation by isoproterenol also resulted in an increase in
venous return. This increase in venous return to the central circulation was blocked
by pronethalol (Nethalide R), one ofthe first beta adrenergic receptor blocking drugs.
In vivo studies of the effects of isoproterenol have clearly demonstrated the dilator
properties of the drug in cutaneous veins, the femoral vein, and the vena cava
through beta adrenergic receptor activation [15]. As recently reviewed by Shepherd
and Vanhoutte [5] in isolated veins isoproterenol depresses spontaneous activity and
depresses the responses to nerve stimulation or to vasoconstrictor drugs such as alpha
adrenergic agonists. Both in the intact organism and in the organ bath, the
venodilator action of isoproterenol is specifically counteracted by drugs known to
block beta adrenergic receptors [5]. This venodilation should pool blood peripherally
and not increase venous return to the heart as found by Kaiser et al. [6]. While it is
true that very high doses of isoproterenol can cause alpha adrenergic receptor
activation and contraction of isolated helical strips of canine saphenous veins, the
concentration of isoproterenol necessary to produce this effect is 1 x 10-5 g/ml [14].
This concentration is at least 40 times that achieved by Kaiser et al. [6].
Thus, in the experiments by Kaiser, Ross, and Braunwald[6], the question remains
as to the mechanism whereby beta adrenergic receptor stimulation withisoproterenol
caused an increase in venous return. The doses of isoproterenol employed by Kaiser
et al. were much lower than those necessary to produce venoconstriction through
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terenol produced venoconstriction due to beta adrenergic receptor stimulation. It is
possible that reflex influences on venomotor tone could have resulted in alpha
adrenergic receptor stimulation ofthe venous circulation and displacement of blood
from the animal. However, the recent data of Imai et al. [16] make this explanation
unlikely. In the latter experiments, elimination ofthe baroreceptor reflex ofsinoaor-
tic origin failed to modify the increase in venous return induced by the infusion of
isoproterenol into the ascending aorta ofthe dog. Bilateral carotid sinus denervation
and vagotomy did not alter the effect of isoproterenol on venous return.
The recent work of Green [17,18] again confirms the finding of an increase in
venous return caused by isoproterenol and postulates a possible mechanism whereby
venodilatation by this agent might increase venous return to the heart. Using an
experimental dog model [19], Green developed evidence for the existence of an
".effective splanchnic back pressure." In these experiments, which employed a right
heart bypass preparation, Green demonstrated that elevations of hepatic venous
pressure produce no change in splanchnic blood flow orportal pressureuntil hepatic
venous pressure is raised to a critical value. As hepatic venous pressure is raised
above this value, portal pressure rises and splanchnic flow falls. This critical value of
hepatic venous pressure is therefore considered to be the "effective splanchnic back
pressure" under conditions in which hepatic venous pressure is less than this value.
Green's experiments [19] have demonstrated that the effective splanchnic back
pressure generates volume in the splanchnic bed. Green noted[18] that isoproterenol
reduced hepatic vascular resistance as determined by measurements of "effective
splanchnic back pressure." Therefore, Green postulated that the increase in venous
return produced by isoproterenol can be wholly or partially accounted for by a
release in splanchnic blood volume caused by a reduction in the effective splanchnic
back pressure. Thus, it is possible that the liver may, through changes in resistance to
splanchnic outflow, act like a "sphincter" which can regulate the transfer of blood
volume from the relatively high pressure system in the portal circulation to the
central venous circulation. This concept is illustrated schematically in Fig. 2.
Since Green was not able to quantitate the effect of beta adrenergic receptor
stimulation on the resistance to blood flow from the portal to the central circulation,
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FIG. 2. A schematic representation of the control of the splanchnic blood volume. See text for details.
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ourpreliminary experiments [20] were undertaken to examine the effects of adrener-
gic receptor
stimulation venous return and on transhepatic resistance to portal
blood flow. For this study, dogs were anesthetized with chloralose and urethane,
vagectomized, ganglionically blocked, and placed on total cardiopulmonary bypass at 1.5 L/min. Isoproterenol (6ttg/min) and norepinephrine(30,ug/min) were infused
for 10-24 minutes. Changes were noted in pump reservoir volume with the central
venous pressure set at 3, 8, or 13 cm H2O. Isoproterenol caused a loss of blood of
20-150 (mean 80i 30) ml from the dogs (p <.05) and norepinephrine a loss of
190-290 (mean 240 ± 30) ml (p <.05). Selective adrenergic blockade with either
phenoxybenzamine
or propranolol or double blockade with both drugs revealed that
the isoproterenol induced volume changes were mediated through beta adrenergic
receptor stimulation, whereas norepinephrine induced volume changes were medi-
ated through both alpha and beta adrenergic receptor stimulation. After the hepatic and mesenteric vasculature was ligated and hence removed from the circulation in
two dogs, almost no change in reservoir volume was noted with isoproterenol or
norepinephrine. These latter data localized the capacity effects of the two catechola-
mines primarily
to the splanchnic vasculature in the dog.
In the animals without
mesenteric vascular ligation, isoproterenol and norepinephrine each resulted in a
decrease of 7 ± 3 (p
< .05) cm H20 in portal venous pressure from a mean of 25 ±4
cm H20
for isoproterenol and a mean of
27 ± 1
cm H20 for norepinephrine. In two
of these animals, hepatic venous return was continuously monitored. With isopro-
terenol or with norepinephrine, hepatic flow increased while the pressure gradient
from portal
to hepatic
vein decreased, indicating a fall in resistance to transhepatic
portal
outflow. Thus, isoproterenol, entirely,
and norepinephrine,
in part, each
caused decreases in venous capacity by beta adrenergic relaxation of a portion ofthe
venous circulation contained within the liver.
This diminution of resistance to portal
blood flow across the liver explains the apparent discrepancy of isoproterenol
associated relaxation of isolated segments of the venous circulation [5,15] with the
displacement of blood from thewhole animal [6,16,17]. This mechanism ofdiminish-
ing transhepatic
vascular resistance may be of major importance in the regulation of
venous capacity.
If the diminution of transhepatic resistance is an important factor in increasing
venous return,
then increasing transhepatic resistance may be important in diminish-
ing
the return of blood the heart. The experiments described above examining the
effect of adrenergic receptor stimulation on systemic capacity and transhepatic
resistance have been carried out with infusions of beta adrenergic receptor agonists.
Over the past
5 years,
in studies on arterial resistance vasculature,
we have estab-
lished that acetylstrophanthidin (a rapidly acting aglycone digitalis preparation) and
digoxin vasoconstrict in both skeletal muscle and the heart through a centrally
mediated neurogenic alpha adrenergic receptor mechanism [21-24].
It is possible that
digitalis may
exert a neurogenic effect on the venous circulation as well. Ross,
Braunwald,
and Waldhausen [25] have demonstrated that the administration of large
doses of acetylstrophanthidin
to the dog on total cardiopulmonary bypass results in a
decrease in venous return to the heart.
This decrease in venous return appears to
result from an increase in resistance to blood flow across the liver with a consequent
increase in portal
vein pressure and a pooling of blood in the mesenteric circulation.
Venting
of the portal
vein in this animal preparation resulted in an increase in venous
return from the animal
an external pump oxygenator which is likely due
diffuse venoconstrictor effect of the drug [26].
Our preliminary unpublished observa-
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portal
vein pressure associated with ouabain (a digitalis glycoside) administration is,
at least in part, mediated through alpha adrenergic receptor stimulation.
The magnitude of either dilation or constriction of a transhepatic "sphincter" may
be importantly related to the control level of transhepatic resistance to portal blood
flow. In our experiments on the effects of isoproterenol and norepinephrine men-
tioned above, the control levels of portal pressure were elevated for the dog[20], and
therefore the absolute volume of blood displaced centrally with beta adrenergic
receptor stimulation may have been greater than under conditions of an initially
normal portal pressure. Explanations for the elevation of portal pressure should
include the possibility ofendotoxin release, which is known to elevate portal pressure
in the dog [27]. This release of endotoxin may have occurred during the extensive
surgical manipulation necessary to set up the preparation. However, the study on the
effects of vasopressin cited below [28] demonstrates that it is also possible to lower
substantially transhepatic resistance to blood flow when portal pressure is initially
normal (7.2 ±1 mm Hg).
A recently published study [28] on the effects of vasopressin on canine hepatic
hemodynamics helps to localize the site of control of transhepatic resistance. The
results from this study demonstrate that infusions of vasopressin into either the
hepatic artery or the portal vein elicit hepatic venous dilation and a quantitatively
similar decrease in portal vascular resistance. This suggests that these alterations in
portal vascular resistance were due to effects on a common outlet resistance site.
Thus, it appears that in addition to increasing arterial resistance and thereby
decreasing inflow to the mesenteric circulation [28], vasopressin also reduces the
resistance to portal blood flow at a site which is likely to be at or beyond the outlets
of the hepatic sinusoids into the hepatic venules. These data, obtained in a different
laboratory, support the concept of the existence of a hepatic venous "sphincter"
which is of importance in regulating portal vein hemodynamics.
Hepatic venous sphincters are thought to be present in several animal species,
including the dog [29-31]. Possible anatomic locations for the sphincters include the
junctions of the hepatic veins with the inferior vena cava [32], the sublobular hepatic
veins [33], and the hepatic sinusoids [34]. Alternatively, it is possible that the entire
hepatic venous system may vasoconstrict [35,36].
In man, Popper[37] described thejunctions ofcentral venules with hepatic veins as
being "funnel-like." Elias and Popper [38] noted that thin-walled hepatic venules in
the human constricted on entering a thick-walled vessel. In neoprene casts of the
hepatic venous system in man made by Gibson [39], the junctions of central venules
and hepatic veins were sometimes retracted. Since the junctions were numerous,
Gibson concluded that junctional constriction was probably the "chief venous
sphincter mechanism in the human liver." Krogh and Lindhard [40] demonstrated
that the human liver and portal vein bed could store and release blood and thereby
control the rate of filling of the heart and thus cardiac output. These data have been
interpreted by Knisely et al. [34] as indicating that the control of the outflow of blood
from livers of healthy humans is an important factor in the control of cardiac output.
Thus, it appears likely that the data obtained using the dog model will be at least
directionally similar to those in man, but the extent to which post-sinusoidal
resistance regulates transhepatic blood flow in the human remains to be documented.
The control of the total venous circulation exerts an important influence
cardiac filling and hence on cardiac output. The possible role of the liver as a
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"sphincter" controlling the return of blood from the relatively high pressure portal
system to the lower pressure central venous system may be a major factor in the
regulation of the distribution of blood volume between the central and splanchnic
vasculature in man. This regulation within the liver could importantly influence
cardiac performance.
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